Form 8-K - Current report:
SEC Accession No. 0001493152-17-015056
Filing Date
2017-12-26
Accepted
2017-12-26 16:05:35
Documents
6
Period of Report
2017-12-19
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 28246
2 ex3-1.htm EX-3.1 95782
3 ex3-1_001.jpg GRAPHIC 104391
4 ex3-1_002.jpg GRAPHIC 234499
5 ex3-1_003.jpg GRAPHIC 61581
6 ex99-1.htm EX-99.1 15063
  Complete submission text file 0001493152-17-015056.txt   692089
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36268 | Film No.: 171274488
SIC: 2835 In Vitro & In Vivo Diagnostic Substances